Joseph Wisniewski, MD
Allergy & Immunology · Chattanooga, TNNPI 1457346835
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 285 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AstraZeneca at 24.1% of the total. 2025 is the largest year on record at $1,502, 2.3 times the $647 reported in 2019. That places this record below the midpoint for allergy & immunology clinicians in TN, where the typical reported total is $6,300.
Across 285 payments — averaging $20.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$649
- Genentech USA, Inc.$512
- Regeneron Healthcare Solutions, Inc.$510
- Takeda Pharmaceuticals U.S.A., Inc.$488
- Sanofi$292
- plus $2K from 22 others
What the payments were for
- Consulting fees$511%
- Food & beverage$5,59597%
- Education$1322%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 66 | $1,392 |
| GSK | 35 | $649 |
| Genentech USA, Inc. | 24 | $512 |
| Regeneron Healthcare Solutions, Inc. | 18 | $510 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $488 |
| Sanofi | 13 | $292 |
| Teva Pharmaceuticals USA, Inc. | 24 | $244 |
| ARS Pharmaceuticals Operations, Inc. | 9 | $222 |
| Amgen | 11 | $219 |
| Novartis | 11 | $184 |
| CSL Behring | 8 | $167 |
| Kaleo, Inc. | 7 | $129 |
| Grifols USA, LLC | 6 | $114 |
| Verona Pharma, Inc. | 4 | $79 |
| Boehringer Ingelheim | 4 | $74 |
| Pfizer | 3 | $66 |
| Biocryst US Sales Co., LLC | 3 | $63 |
| Pharming Healthcare, Inc. | 4 | $61 |
| Optinose US, Inc. | 3 | $59 |
| Octapharma USA, Inc. | 1 | $58 |
| ADMA Biomanufacturing LLC | 2 | $51 |
| Alk-abello, Inc | 2 | $40 |
| Cycle Pharmaceuticals Inc | 1 | $29 |
| Blueprint Medicines Corporation | 1 | $19 |
| Greer Laboratories, Inc. | 1 | $17 |
| Circassia Inc. | 1 | $16 |
| Merck | 1 | $13 |
| Mylan Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$122
How this compares
$5,778 in reported general payments places this provider in the 45th percentile of 79 allergy & immunology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XolairOmalizumab | 60 | $206,833 |
| Dupixent PenDupilumab | 16 | $70,663 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 43 | $30,273 |
| Spiriva RespimatTiotropium Bromide | 14 | $10,546 |
| Arnuity ElliptaFluticasone Furoate | 23 | $9,954 |
| Azelastine Hcl | 257 | $7,112 |
| Spiriva HandihalerTiotropium Bromide | 12 | $6,270 |
| Epinephrine | 28 | $6,234 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $5,470 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 30 | $4,865 |
| Ipratropium Bromide | 91 | $3,051 |
| Montelukast Sodium | 77 | $1,035 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $990 |
| Wixela InhubFluticasone Propion/Salmeterol | 12 | $961 |
| Fluticasone Propionate | 76 | $960 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Arnuity Ellipta, Breo Ellipta | $649 | $45,69780 claims |
| Boehringer IngelheimSpiriva Respimat | $74 | $10,54614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 79 allergy & immunology providers in Tennessee.
Other allergy & immunology in Chattanooga
- Marc CromieChattanooga$106K
- Todd LevinChattanooga$64K
- Susan RaschalChattanooga$40K
- Jennifer PatelChattanooga$12K
- Lee PerryChattanooga$10K
- David ChaffinChattanooga$5K
- Jessica van MasonChattanooga$5K
- Taylor AtchleyChattanooga$4K
- Michael HollieChattanooga$3K
- Paul CarterChattanooga$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.